Helping the work live on

Helping the work live on

Donna Bradley-Robinson

During September, MS Research Australia and over 140 other charities across Australia, will be working together with the Include a Charity campaign to highlight the vital role that bequests play in benefiting all communities in need.

Donna Bradley-Robinson explains what motivated her to include MS Research Australia in her Will. ‘In 1994, just one year after getting married, at the age of 29. I was diagnosed with relapsing-remitting MS.’

‘MS changed the course of my life – my marriage ended and my career in the Police force changed from patrol duties to a desk job. I then became determined to learn as much about the disease as I could and also what research was being done to help people living with MS. In 20 years I have seen so much progress with treatments and it is this ongoing effort and the incredible commitment to supporting important MS research projects that has inspired me to leave a bequest to MS Research Australia.’

‘I encourage people with MS to be aware of the efforts being made to support their needs for a better life. MS Research Australia provides a vital role in keeping us informed on all of the latest research findings as well as funding MS projects that will someday find a cure.’

‘Whilst there is ultimately only one priority and that is to find a cure, research must continue to explore all avenues to discover the causes and better treatments so future generations can be prevented from being affected by MS.’

Gifts left to charities in wills are made by people from all walks of life, not just the wealthy. Often, gifts are left by ordinary, hard working individuals who want to know they’ll be contributing to a better society after they’re gone.

If you would like more details about leaving a bequest to MS Research Australia, please call 1300 356 467 or visit



New campaign shines light on life-changing MS Nurse Care

MS Australia has today launched a new campaign at Parliament House on World MS Day (30 May) to raise awareness of the crucial role played by MS Nurses.

Revolutionising MS Treatment: New form of Tysabri® recommended for PBS listing

The Pharmaceutical Benefits Advisory Committee (PBAC) has recommended the listing of natalizumab (Tysabri®) pre-filled syringe for subcutaneous (under the skin) injection on the Pharmaceutical Benefit Scheme (PBS).

What us to keep you in the loop? Subscribe today!

  • Enter your details

Read More
brain scan

Newsletter subscription

  • Enter your details

Helping the work live on